Shore Capital view: Creo Medical (‘CREO’) is at a commercial inflection point. In FY25, sales of its surgical endoscopy tools grew substantially (+50%) despite a tightening cost base (-20%), establishing that
Share Talk Weekly Stock Market News Review, Sunday 22nd February 2026
FTSE 100 ends the week higher after touching a fresh record. The FTSE 100 finished the session in positive territory after surging to a new intraday high in the wake
RNS Hotlist with Zak Mir: PLSR, KOS, UMR, WCAT, SBTX & SWC
Pulsar Helium Inc. (PLSR), a primary helium company, announced that, further to its announcement on February 19, 2026 regarding the Placing, conducted by way of accelerated bookbuild.